(ENSG) The Ensign - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012

ENSG: Care, Nursing, Rehabilitation, Housing, Services, Healthcare

The Ensign Group, Inc. (NASDAQ:ENSG) is a significant player in the healthcare services sector, focusing on skilled nursing, senior living, and rehabilitative care. This company is structured into two main segments: Skilled Services and Standard Bearer, each catering to different aspects of healthcare delivery.

The Skilled Services segment is the operational backbone, managing skilled nursing facilities and rehabilitation therapy services. These services are crucial for patients needing prolonged care, whether due to chronic conditions or age-related health issues. Beyond the basics, they offer specialized care such as on-site dialysis and ventilator care, which are essential for patients with severe medical needs. Additionally, they provide standard services that enhance patient comfort and well-being, including nutritional programs and social activities.

The Standard Bearer segment adds a strategic real estate dimension to their operations. By owning and leasing properties to healthcare operators, they create a steady revenue stream that supports their core healthcare services. This segment not only diversifies their income but also underscores their commitment to maintaining high-quality facilities.

Ensign Groups service portfolio extends beyond facilities to include ancillary services like mobile diagnostics and patient transportation. These offerings ensure comprehensive care, whether patients are at home or in a facility. Their operational footprint spans multiple states, indicating a strategic presence in key markets.

From an investment perspective, Ensign Group presents an interesting case. Their dual focus on healthcare and real estate provides a balanced risk profile. The real estate segment offers stable cash flows, while the healthcare services tap into the growing demand for post-acute care. Investors should consider their operational efficiency and ability to scale, which are crucial in the healthcare industry.

Financially, the company has a market cap of over $7.8 billion, with a P/E ratio indicating a premium valuation. Their price-to-book ratio suggests strong asset utilization, which is favorable for investors seeking growth. The diversification across services and real estate positions Ensign Group as a resilient player in the healthcare sector.

For those evaluating investment opportunities in healthcare, Ensign Groups model offers insights into how integrated services and strategic asset management can drive value. Their approach to patient care and operational efficiency makes them a company worth considering for those looking at the intersection of healthcare and real estate.

Additional Sources for ENSG Stock

ENSG Stock Overview

Market Cap in USD 7,397m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 2007-11-09

ENSG Stock Ratings

Growth 5y 83.3%
Fundamental 69.9%
Dividend 50.1%
Rel. Strength 9.49
Analysts 4.5/5
Fair Price Momentum 146.24 USD
Fair Price DCF 75.99 USD

ENSG Dividends

Dividend Yield 12m 0.18%
Yield on Cost 5y 0.69%
Annual Growth 5y 3.68%
Payout Consistency 98.6%

ENSG Growth Ratios

Growth Correlation 3m -53.1%
Growth Correlation 12m 36%
Growth Correlation 5y 92.2%
CAGR 5y 30.29%
CAGR/Max DD 5y 1.09
Sharpe Ratio 12m 0.29
Alpha 7.03
Beta 0.982
Volatility 23.74%
Current Volume 779.8k
Average Volume 20d 348.7k
What is the price of ENSG stocks?
As of April 04, 2025, the stock is trading at USD 133.90 with a total of 779,813 shares traded.
Over the past week, the price has changed by +4.30%, over one month by +3.15%, over three months by +1.11% and over the past year by +10.56%.
Is The Ensign a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, The Ensign (NASDAQ:ENSG) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 69.91 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENSG as of April 2025 is 146.24. This means that ENSG is currently overvalued and has a potential downside of 9.22%.
Is ENSG a buy, sell or hold?
The Ensign has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy ENSG.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ENSG stock price target?
According to ValueRays Forecast Model, ENSG The Ensign will be worth about 164.9 in April 2026. The stock is currently trading at 133.90. This means that the stock has a potential upside of +23.15%.
Issuer Forecast Upside
Wallstreet Target Price 164.8 23.1%
Analysts Target Price 169.5 26.6%
ValueRay Target Price 164.9 23.2%